Target intelligence / Profile preview

Gram-positive bacterial cell membrane and associated biosynthetic machinery

Molecular classification
Enzyme, Lipid, Other
01

Overview

The Gram-positive bacterial cell membrane and its associated biosynthetic machinery constitute a vital structural and functional complex essential for bacterial viability and pathogenesis (StatPearls: NBK459363). This target system includes the cytoplasmic phospholipid bilayer and the intricate enzymatic pathways responsible for synthesizing the thick, protective peptidoglycan layer characteristic of Gram-positive species. Key molecular components include penicillin-binding proteins (PBPs), which facilitate the final stages of cell wall cross-linking, and lipid intermediates like Lipid II that transport precursors across the membrane (Microbiology and Molecular Biology Reviews, 2008). In clinical practice, this machinery is the focal point for many of the most effective antibiotic classes, such as beta-lactams, glycopeptides, and lipopeptides. For instance, daptomycin targets the membrane directly by causing rapid depolarization and ion leakage (StatPearls: NBK470413), while vancomycin binds to the D-Ala-D-Ala terminus of peptidoglycan precursors to inhibit synthesis. Because these biosynthetic processes are absent in human cells, they provide a high degree of selective toxicity, although the rise of resistant strains like MRSA and VRE necessitates the ongoing development of next-generation inhibitors (Nature Reviews Microbiology, 2015).

Other names
Gram-positive cell envelopeBacterial cytoplasmic membranePeptidoglycan biosynthetic pathway
02

Mechanism of action

Inhibition of peptidoglycan transpeptidation via PBP binding, sequestration of Lipid II to halt cell wall assembly, and calcium-dependent membrane depolarization leading to ion leakage (StatPearls: NBK470413, NBK459363).

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyMembrane potential maintenanceIon homeostasisOsmotic protectionCell division
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityRhabdomyolysisHypersensitivity reactionsAntibiotic resistance (e.g., MRSA, VRE)Ototoxicity
06

Interacting drugs

Daptomycin

9 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Minimum Bactericidal Concentration (MBC)ProcalcitoninC-reactive protein (CRP)Creatine phosphokinase (CPK)

Beyond the preview

Go deeper on Gram-positive bacterial cell membrane and associated biosynthetic machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-positive bacterial cell membrane and associated biosynthetic machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call